Moreover, Pparα modulates lipid metabolism, promotes fatty acid beta-oxidation and regulates lipid fatty acid circulation, [54,55], thus its upregulation could result in a reduction of available fatty acid for triglyceride synthesis and an interruption of NAFLD progression. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.